Document is current
Any future updates will be listed below
-
Authors
Driedger, Jan H.
Schröter, Julian
,
Hertzberg, Christoph
Weschke, Bernhard
Kaindl, Angela M.
Lücke, Thomas
Thiels, Charlotte
Klotz, Kerstin Alexandra
Fazeli, Walid
Rostásy, Kevin
Wiethoff-Ubrig, Lucia
Kaiser, Olaf
Trollmann, Regina
Mammadova, Dilbar
Schubert-Bast, Susanne
Bach, Alexia
Eckenweiler, Matthias
Schönberger, Jan
Martakis, Kyriakos
Hahn, Andreas
Brockmann, Knut
Dreha-Kulaczewski, Steffi
Weiss, Deike
Denecke, Jonas
Muhle, Hiltrud
Arelin, Maria
Merkenschlager, Andreas
Borggräfe, Ingo
Roser, Timo
Ebrahimi-Fakhari, Daniel
Fiedler, Barbara
Schlump, Jan-Ulrich
Köster, Ilka
Korenke, Christoph
Alber, Michael
Ruf, Susanne
Feucht, Martha
Scholl, Theresa
Syrbe, Steffen https://orcid.org/0000-0003-2543-4844
Saffari, Afshin
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG2126)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 4 December 2024
First Online: 6 January 2025
Declarations
:
: This clinical trial will be conducted in compliance with the protocol and in accordance with the following regulatory requirements: consensus ethical principles derived from international guidelines, including the Declaration of Helsinki and the Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines, applicable International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and Good Clinical Practice (GCP) Guidelines, and relevant national laws and regulations. The clinical trial has been approved by the national authority with the involvement of the national ethics committee (EU CT No: 2022–502332-39–00).
: Not applicable.
: The authors declare that they have no competing interests.
